The first Onconova Therapeutics trade was made in Q3 2018.
Since then Jim Simons bought shares ten more times and sold shares on twelve occasions. The investor completely sold their stake between Q2 2024 and Q3 2024.
Avg closing price
Price range
Sold -218 Thousand shares
Q3 2024
Avg closing price
-
Price range
-
-
-
Sold 18.7% shares (-50.1 Thousand shares)
Q2 2024
Avg closing price
$1.00
Price range
$1.00
-
$1.00
Increased shares by 34.9% (+69.4 Thousand shares)
Q1 2024
Avg closing price
$0.77
Price range
$0.67
-
$1.01
Increased shares by 8.2% (+15.1 Thousand shares)
Q4 2023
Avg closing price
$0.68
Price range
$0.62
-
$0.79
Sold 21.7% shares (-51 Thousand shares)
Q3 2023
Avg closing price
$0.91
Price range
$0.71
-
$1.15
Increased shares by 62.1% (+89.9 Thousand shares)
Q2 2023
Avg closing price
$1.08
Price range
$0.67
-
$1.42
Sold 13.6% shares (-22.9 Thousand shares)
Q1 2023
Avg closing price
$0.87
Price range
$0.69
-
$1.42
Sold 18.3% shares (-37.4 Thousand shares)
Q4 2022
Avg closing price
$0.75
Price range
$0.63
-
$0.97
Sold 38.5% shares (-128 Thousand shares)
Q3 2022
Avg closing price
$1.21
Price range
$0.88
-
$1.45
Increased shares by 3.6% (+11.6 Thousand shares)
Q2 2022
Avg closing price
$1.35
Price range
$1.04
-
$1.90
Increased shares by 140.8% (+188 Thousand shares)
Q1 2022
Avg closing price
$1.85
Price range
$1.46
-
$2.82
New holding (+134 Thousand shares)
Q4 2021
Avg closing price
$3.22
Price range
$2.49
-
$3.73
Sold -246 Thousand shares
Q2 2021
Avg closing price
$9.05
Price range
$6.28
-
$16.20
New holding (+246 Thousand shares)
Q1 2021
Avg closing price
$15.09
Price range
$7.52
-
$26.40
Sold -79.2 Thousand shares
Q3 2020
Avg closing price
$9.96
Price range
$3.11
-
$20.85
New holding (+79.2 Thousand shares)
Q2 2020
Avg closing price
$6.11
Price range
$4.17
-
$9.21
Sold -43 Thousand shares
Q1 2020
Avg closing price
$6.28
Price range
$4.35
-
$9.00
Increased shares by 1311.7% (+40 Thousand shares)
Q4 2019